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Letter to the Editor
this criteria correspond to known functional groups ofA Unified Nomenclature System for
receptors. This procedure yields six subfamilies. All thethe Nuclear Receptor Superfamily
unusual receptors that contain only one of the two con-
served domains (C or E) were grouped into a separate
subfamily (subfamily 0) irrespective of their evolutionaryNuclear hormone receptors (NRs) are important tran-
origin. Within subfamilies, groups of receptors are de-scriptional regulators involved in widely diverse physio-
fined as the most internal branches with bootstrap val-logical functions such as control of embryonic develop-
ues above 90%. In this nomenclature system, the num-ment, cell differentiation, and homeostasis (Gronemeyer
ber of a given receptor inside a group does not carryand Laudet, 1995; Mangelsdorf et al., 1995). In addition,
any specific information. In many cases these groupsthese molecules are extremely important in medical re-
contain arthropod and vertebrate members. The varioussearch since a large number of them are implicated in
homologs of the same gene in invertebrates (e.g., Dro-diseases such as cancer, diabetes, or hormone resis-
sophila and Caenorhabditis) have the same name. It istance syndromes. Some of the NRs act as ligand-induc-
ible transcription factors, while a large number of them
have no defined ligand and are hence described as ªor-
phanº receptors (Enmark and Gustafsson, 1996). Over
the last decade, workers in the field have described
more than 300 sequences of NRs using an increasingly
complex and baroque nomenclature. The existence of
several names for the same gene is an acute problem
for the orphan receptors, which often cannot be de-
scribed by their function, particularly at the moment of
their discovery. As discussed during the Seventh Inter-
national CBT Symposium on ªNuclear Orphan Recep-
torsº in Huddinge, Sweden (September 9±12, 1995), this
plethora of names has become more and more confus-
ing and now constitutes a barrier for understanding of
newly acquired knowledge to researchers outside as
well as within the field. For that reason, four of us (V. L.,
J. A., J.-A. G., and W. W.) agreed to form a committee
for the nomenclature of NRs. It is the purpose of this
paper to recommend names for the subfamilies and
groups of receptors based on a phylogenetic tree con-
necting all known NR sequences. This system, based
on the evolution of the two well-conserved domains of
NRs (the DNA-binding C domain and the ligand-binding
E domain), offers a practical and significant framework
to which subsequent genes can be easily added. The
resulting nomenclature has now been endorsed by over
40 scientists1 many of whom contributed to defining the
nomenclature and to preparing this letter. This nomen-
clature has been discussed with the International Union
of Pharmacology Committee on Receptor Nomenclature
and Drug Classification (NC-IUPHAR). A subcommittee
of NC-IUPHAR entitled ªNuclear Receptorsº will be set
up to further clarify receptor nomenclature to integrate
structure and function.
A summary of the new nomenclature is presented in
Table 1.
Rationale of the System
A complete description of the alignment procedures,
Figure 1. Phylogenetic Tree Connecting the 65 Known NR Genestree reconstruction methods, and evolutionary implica-
in Vertebrates, Arthropods, and Nematodestions can be found in Laudet, 1997. A more complete
The length of the branches is proportional to the bootstrap value.description of our system can be found in a web site
Only one version of each individual gene was included in the tree.devoted to the regular implementation of this nomencla-
Subfamilies are indicated by arabic numerals at the extreme rightture (http://www.ens-lyon.fr/LBMC/LAUDET/nomenc.
of the figure, groups by capital letters and brackets, and individual
html). Briefly, subfamilies are defined as the last most genes by arabic numerals together with a representative name. The
internal branches of the evolutionary tree with ro- scale shows the length of the maximum possible bootstrap value
bustness (ªbootstrapº) values above 90% (boxed in Fig- (100). The bootstrap values defining the subfamilies are boxed, ex-
cept in the case of GCNF1 defined by only one member.ure 1). In the case of the NRs, the groups defined with
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Table 1. ContinuedTable 1. A Proposed Nomenclature for Nuclear Receptors
Subfamily AccessionSubfamily Accession
and Group NR/Gene Trivial Names Number and Group NR/Gene Trivial Names Number
1A NR1A1 TRa, c-erbA-1, THRA M24748 4A NR4A1 NGFIB, TR3, N10, L13740
NUR77, NAK1NR1A2 TRb, c-erbA-2, THRB X04707
1B NR1B1 RARa X06538 NR4A2 NURR1, NOT, RNR1, X75918
HZF-3, TINORNR1B2 RARb, HAP Y00291
NR1B3 RARg, RARD M57707 NR4A3 NOR1, MINOR D38530
NR4A4 DHR38, NGFIB U367621C NR1C1 PPARa L02932
NR1C2 PPARb, NUC1, L07592 CNR8, C48D5 U13076
5A NR5A1 SF1, ELP, FTZ-F1, D88155PPARd, FAAR
NR1C3 PPARg L40904 AD4BP
NR5A2 LRH1, xFF1rA, U935531D NR1D1 REVERBa, EAR1, M24898
EAR1A xFF1rB, FFLR, PHR,
FTFNR1D2 REVERBb, EAR1b, L31785
BD73, RVR, HZF2 NR5A3 FTZ-F1 M63711
5B NR5B1 DHR39, FTZF1B L06423NR1D3 E75 X51548
1E NR1E1 E78, DR-78 U01087 6A NR6A1 GCNF1, RTR U14666
0A NR0A1 KNI, Knirps X133311F NR1F1 RORa, RZRa U04897
NR1F2 RORb, RZRb Y08639 NR0A2 KNRL, Knirps related X14153
NR0A3 EGON, Embryonic X16631NR1F3 RORg, TOR U16997
NR1F4 HR3, DHR3, MHR3, M90806 gonad, EAGLE
NR0A4 ODR7 U16708GHR3, CNR3,
CHR3 U13075 NR0A5 Trithorax M31617
0B NR0B1 DAX1, AHCH S747201G NR1G1 CNR14 U13074
1H NR1H1 ECR M74078 NR0B2 SHP L76571
NR1H2 UR, OR-1, NER1, U07132
Note: subfamilies and groups are defined in the text. The groupsRIP15, LXRb
contain highly related genes with often paralogous relationship inNR1H3 RLD1, LXR, LXRa U22662
vertebrates (e.g., RARA, RARB, and RARG). The term isoform isNR1H4 FXR, RIP14, HRR1 U09416
reserved for different gene products originating from the same gene1I NR1I1 VDR J03258
due to alternative promoter usage or splicing, or alternative initiationNR1I2 ONR1, PXR, SXR, X75163
of translation.BXR
NR1I3 MB67, CAR1, CARa Z30425
NR1I4 CAR2, CARb AF00932
1J NR1J1 DHR96 U36792 not possible to define a strict percentage identity limit
1K NR1K1 NHR1 U19360 for belonging to a particular group but members of the
2A NR2A1 HNF4 X76930 same group in general share at least 80%±90% identity
NR2A2 HNF4G Z49826
in the DNA-binding domain and at least 40%±60% inNR2A3 HNF4B Z49827
the ligand-binding domain.NR2A4 DHNF4, HNF4D U70874
Our system is based on the nomenclature system that2B NR2B1 RXRA X52773
NR2B2 RXRB, H-2RIIBP, M84820 was developed for cytochrome P450 by Nebert et al.
RCoR-1 (1987). This system has proven to be convenient and
NR2B3 RXRG X66225 flexible, allowing for the inclusion of an ever increasing
NR2B4 USP, Ultraspiracle, X52591
number of cytochrome P450 genes. We anticipate that2C1, CF1
our system will provide similar advantages.2C NR2C1 TR2, TR2-11 M29960
Since editors of computerized nucleotide sequenceNR2C2 TR4, TAK1 L27586
2D NR2D1 DHR78 U36791 databases discourage the use of Greek letters and hy-
2E NR2E1 TLL, TLX, XTLL S72373 phens in gene names, we have avoided their use except
NR2E2 TLL, Tailless M34639 for the distinction between recent products of tetra-
2F NR2F1 COUP-TFI, COUPTFA, X12795
ploidization events in species such as zebrafish or Xeno-EAR3, SVP44
pus. We therefore recommend that gene subfamiliesNR2F2 COUP-TFII, M64497
be designated by arabic numerals, groups by capitalCOUPTFB, ARP1,
SVP40 letters, and individual genes by arabic numerals. In the
NR2F3 SVP, COUP-TF M28863 case of functionally and structurally distinct variants de-
NR2F4 COUP-TFIII, X63092 rived from the same gene (e.g., the isoforms SF1 and
COUPTFG
ELP, the two products of the mouse Ftzf1 gene) a lower-NR2F5 SVP46 X70300
case letter is added at the end of the name. For example,NR2F6 EAR2 X12794
SF1 can be referred to as NR5A1a and ELP as NR5A1b.3A NR3A1 ERa X03635
NR3A2 ERb U57439 Only major isoforms can be considered at this stage,
3B NR3B1 ERR1, ERRa X51416 and implementation of the isoform nomenclature will be
NR3B2 ERR2, ERRb X51417 set up in the web page.
3C NR3C1 GR X03225 Use of the Nomenclature SystemNR3C2 MR M16801
In each manuscript dealing with NRs, it is recommendedNR3C3 PR M15716
that the receptor(s) be identified by the official name(s)NR3C4 AR M20132
at least once in the Summary and the Introduction. No
continued
hyphen is necessary between NR and the subfamily,
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group, and gene numbers. Once the name has been
established (e.g., ªthis paper describes GCNF1 [NR6A1],
a member of the nuclear hormone receptor superfam-
ilyº), authors may use the trivial name for the remainder
of the manuscript. When authors describe a new NR
sequence they are kindly requestedÐafter acceptance
of the paper but before reading of galley proofs, to send
the amino acid sequence of the receptor in complete con-
fidentiality to V. L. (e-mail, vincent.laudet@ens-lyon.fr;
fax, 33 4 72 72 80 80; phone, 33 4 72 72 81 90). An
acknowledgment of receipt will be immediately sent by
e-mail or fax, and the official names will be returned
within a week together with an evolutionary tree.
Nuclear Receptors Nomenclature Committee2,3
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